Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo), Following 3 Doses of Active Drug (CDP870).

Autores
Categoría Estudio primario
Registro de estudiosclinicaltrials.gov
Año 2004
Cargando información sobre las referencias
A 26 week maintenance study of CDP870 in Crohn\'s disease
Epistemonikos ID: a84e3c675d2c0c9010c1c23c38f40bd87552f040
First added on: Jul 30, 2018